drugset

drugset / Trial / NCT00530556

Insomnia and Daytime Function in Osteoarthritis

NCT00530556 ↗

Phase 4 Completed 170 enrolled Sanofi

RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy and safety of zolpidem at doses up to 10 mg compared to placebo in patients with insomnia associated with osteoarthritis

Timeline

Start: 2003-03
Primary completion: 2004-06
Completion: 2004-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zolpidem	Small molecule	10 mg	—

Indications